{"denoms":[{"counts":[{"groupId":"BG000","value":"68"}],"units":"Participants"}],"groups":[{"description":"Pasireotide montherapy (0.6 mg bid to 0.9 mg bid) was administered until the biochemical control was achieved and if not achieved, a combination was administered: pasireotide (0.9 mg bid) + cabergoline (0.5 QD to 1 mg QD). Patients were able to add cabergoline at anytime during core and extension","id":"BG000","title":"All Patients"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"64"}]}],"title":"< 65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"≥ 65 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"8"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"44"}]}],"title":"Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Native American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"De novo"},{"categories":[{"measurements":[{"groupId":"BG000","value":"58"}]}],"title":"Persistent/recurrent"}],"description":"De novo = newly diagnosed and persistent/recurrent = xxxxxxxx","paramType":"NUMBER","title":"Cushing's disease status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}]}],"title":"Mild"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"Moderate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Severe"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"}]}],"title":"Not done"}],"description":"Clinical symptoms of CD for facial rubor by severity","paramType":"NUMBER","title":"Clinical symptoms of facial rubor","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"Mild"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Moderate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Severe"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}],"title":"Not done"}],"description":"Clinical symptoms of CD for hirsutism by severity","paramType":"NUMBER","title":"Clinical symptoms of hirsutism","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"Mild"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Moderate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"Severe"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"}]}],"title":"Not done"}],"description":"Clinical symptoms of CD for striae by severity","paramType":"NUMBER","title":"Clinical symptoms of striae","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}]}],"title":"Mild"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"Moderate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Severe"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"}]}],"title":"Not done"}],"description":"Clinical symptoms of CD for supraclavicular fat pad by severity","paramType":"NUMBER","title":"Clinical symptoms of supraclavicular fat pad","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"}]}],"title":"Mild"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"Moderate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Severe"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"}]}],"title":"Not done"}],"description":"Clinical symptoms of CD for dorsal fat pad severity","paramType":"NUMBER","title":"Clinical symptoms of dorsal fat pad","unitOfMeasure":"Participants"}]}